Summary & Overview
HCPCS G9897: ADT Not Given with External Beam Radiotherapy to Prostate
HCPCS Level II code G9897 denotes documentation that androgen deprivation therapy (ADT) was not prescribed or administered in combination with external beam radiotherapy (EBRT) to the prostate, with no reason recorded. Nationally, this code matters because it captures care decisions and documentation gaps in prostate cancer treatment pathways where combined modality therapy is considered. Proper use of the code informs quality measurement and claims processing when ADT omission lacks a stated rationale.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for G9897, guidance on expected service lines and sites of care, and a description of what stakeholders monitor when this code appears on claims. The publication outlines likely benchmarks and policy considerations tied to documentation completeness, clinical appropriateness checks, and audit risk when reasons for therapy omission are not recorded.
This summary provides national context for clinicians, billing staff, and policy analysts about where G9897 fits within prostate cancer treatment documentation and the implications for claims handling and quality measurement. Data not available in the input includes specific payer coverage rules, related ICD-10 pairings, and detailed taxonomies.
Billing Code Overview
HCPCS Level II code G9897 documents patients who were not prescribed or administered androgen deprivation therapy (ADT) in combination with external beam radiotherapy (EBRT) to the prostate, with the reason not given. This code captures a specific clinical scenario where ADT was not used alongside EBRT for prostate cancer care but no documented rationale is provided.
-
Service type: Documentation of omission of a combined therapy (ADT not given with EBRT)
-
Typical site of service: Radiation oncology or outpatient oncology visit where treatment decisions and documentation about combined modality therapy are recorded.
Clinical & Coding Specifications
Clinical Context
A typical patient is a man diagnosed with localized or locally advanced prostate cancer who is scheduled for external beam radiotherapy (EBRT) to the prostate. In this scenario, androgen deprivation therapy (ADT) was not prescribed or administered in combination with EBRT, and no reason for omission was documented in the medical record. The clinical workflow begins with evaluation by a radiation oncologist and urologist, staging with prostate-specific antigen (PSA), digital rectal exam, and imaging as indicated (MRI or CT, bone scan for higher-risk disease). A treatment plan for EBRT is created, simulation and CT-based planning are completed, and daily image-guided radiotherapy sessions are delivered. Documentation should capture decision-making about systemic therapy; in this scenario ADT was expected but not given, and the absence of a documented reason triggers use of the billing code G9897 to indicate EBRT to the prostate without concurrent ADT with no reason provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or technical difficulty of radiation planning or delivery is substantially greater than typical for EBRT. |
23 |